QuadraMed Releases Enhanced Version of Its Enterprise Solutions
19 Junio 2007 - 1:25PM
Business Wire
QuadraMed� Corporation (Amex:QD) today announced general
availability of the QuadraMed M5 release. This release includes a
comprehensive series of enhancements across the company�s
Care-Based Revenue Cycle solutions for Access and Identity
Management, Care Management, Health Information and Revenue Cycle
Management. Developed in cooperation with QuadraMed clients, the
release provides significant increases in overall functionality and
capability to help clients improve their quality of care and
leverage those improvements into positive financial performance. To
improve quality and patient safety, QuadraMed M5 provides
enhancements to nine Care Management products including QuadraMed
Patient and Medication Charting, Order Management, Pharmaceutical
Checking and the Clinical Workstation � Physician module, which
incorporates Clinician Access and Documentation, Prescription
Writing and CPOE (Computerized Physician Order Entry). These
enhancements include substantial data retrieval and display
improvements for ease of use, built-in Intelligent Care Sets� for
reminders and patient care considerations, and alerts and warnings
to further improve clinical decision support. The Emergency
Department is the source for approximately fifty percent of the
admissions for many hospitals. To improve efficiency and safety,
the QuadraMed M5 release adds enhanced capability to track ED
patients in the Access Management products. And to increase
productivity in Health Information Management (HIM) departments,
the release provides for improved workflow by centralizing access
to the information used to efficiently code an encounter using the
Medical Records Abstract/DRG product. Within QuadraMed�s Revenue
Cycle Management solution, a major upgrade was made to the manner
in which clinicians are identified and associated with a patient�s
visit. The Revenue Cycle Management products now include support
for the National Provider Identifier and identifying clinicians in
roles other than physician. The highly rated QuadraMed EDI
applications now provide greater support to the evolving use of 835
for posting payments and adjustments, and process enhancements were
made for use in the creation of 837 electronic claims. QuadraMed�s
Central Business Office product now includes exception-driven
aggregator worklist functionality that can span multiple hospitals.
The foundational components of the QuadraMed Care-Based Revenue
Cycle include solutions for Access and Identity Management, Care,
Health Information and Revenue Cycle Management. These end-to-end
solutions are designed to optimize the patient experience and help
clients to leverage quality care into financial health, enabling
them to receive the proper reimbursement in the shortest time, at
the lowest administrative cost. For information about all QuadraMed
Care-Based Revenue Cycle solutions and related services, visit
www.quadramed.com or call 800.393.0278. About QuadraMed Corporation
QuadraMed Corporation advances the success of healthcare
organizations through IT solutions that leverage quality care into
positive financial outcomes. Using QuadraMed�s Care-Based Revenue
Cycle solutions, which are designed to optimize the patient
experience and leverage quality of care into payment, our clients
seek to receive the proper reimbursement, in the shortest time, at
the lowest administrative cost. QuadraMed delivers real-world
solutions that help healthcare professionals deliver outstanding
patient care with significant efficiency. Behind our products and
services is a staff of 600 professionals whose experience and
dedication to service have earned QuadraMed the trust and loyalty
of customers at approximately 2,000 healthcare provider facilities.
Cautionary Statement on Risks Associated with QuadraMed�s
Forward-Looking Statements This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995 by QuadraMed that are
subject to risks and uncertainties. The words "believe," "expect,"
"anticipate," "intend," "plan," "estimate," "may," "should,"
"could," and similar expressions are intended to identify such
statements. Forward-looking statements are not guarantees of future
performance and are to be interpreted only as of the date on which
they are made. QuadraMed undertakes no obligation to update or
revise any forward-looking statement except as required by law.
QuadraMed advises investors that it discusses risk factors and
uncertainties that could cause QuadraMed�s actual results to differ
from forward-looking statements in its periodic reports filed with
the Securities and Exchange Commission ("SEC"). QuadraMed�s SEC
filings can be accessed through the Investor Relations section of
our website, www.quadramed.com, or through the SEC�s EDGAR Database
at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833). QuadraMed
and Intelligent Care Sets are registered trademarks of QuadraMed
Corporation. Care-Based Revenue Cycle is a trademark of QuadraMed
Corporation. All other trademarks are the property of their
respective holders.
Quadramed (AMEX:QD)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Quadramed (AMEX:QD)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024
Real-Time news about Quadramed Corp. (American Stock Exchange): 0 recent articles
Más de QuadraMed Corporation ArtÃculos de Noticias